RYAM Announces Strong Second Quarter 2024 Results

In This Article:

Increases 2024 EBITDA and Free Cash Flow Guidance

  • Net sales for the second quarter of $419 million, up $34 million from prior year quarter

  • Income from continuing operations for the second quarter of $8 million, up $24 million from prior year quarter

  • Adjusted EBITDA from continuing operations for the second quarter of $68 million, up $41 million from prior year quarter, including $10 million of CEWS benefits recognized

  • Total debt of $778 million; Net Secured Debt of $659 million with a covenant net secured debt ratio of 3.4 times

  • 2024 Adjusted EBITDA guidance increased to $205 million to $215 million

  • 2024 Adjusted Free Cash Flow guidance increased to $100 million to $110 million

  • Given the upgraded guidance, the Company is targeting a covenant net secured debt ratio of less than 3.0 times by the end of 2024

JACKSONVILLE, Fla., August 06, 2024--(BUSINESS WIRE)--Rayonier Advanced Materials Inc. (NYSE:RYAM) (the "Company") today reported results for its second quarter ended June 29, 2024.

"The Company delivered another solid quarter on its financial results as we continued to improve our product mix and manage operating costs. Demand for cellulose specialties has remained higher than expectations and margins have improved as we have minimized losses associated with commodity viscose pulp driven by our decision to suspend operations at our Temiscaming High Purity Cellulose plant. Along with solid EBITDA results, the Company generated $69 million of Adjusted Free Cash Flow, which was supported by the $39 million sale of our refund rights related to our softwood lumber duties. As a result, we reduced our net secured debt leverage ratio to 3.4 times covenant EBITDA," stated De Lyle Bloomquist, President and CEO of RYAM. "In addition to the solid financial results, we have also made significant progress on executing our Biomaterials strategy. The bioethanol facility in Tartas began shipments in April and is ramping up production. We also continue to advance other Biomaterials projects, including bioethanol and prebiotics at our Fernandina and Jesup plants, respectively.

"With the better-than-expected start to 2024, reduced exposure to commodity viscose pulp, progress in reducing operating costs and tightening market dynamics, we are increasing our full-year 2024 Adjusted EBITDA guidance to $205 to $215 million and Adjusted Free Cash Flow to $100 to $110 million. With this improvement in our financial metrics, we are confident that we will refinance our senior secured notes prior to them becoming current in early 2025," concluded Mr. Bloomquist.